WAYNE, Pa., July 29, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced it was awarded two group purchasing agreements with ...

Teleflex focuses on the sale of medical technology products, generally used in hospitals and health centers. I think that development and innovation in new products, expansion of technologies, and the ...

No-moat Teleflex’s TFX third-quarter results came mostly in line with our expectations. We are maintaining our $211 fair value estimate, and the shares appear about fairly valued. Management raised ...

WAYNE, Pa., July 01, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX), a leading global provider of medical technologies, today announced that it has completed the previously announced ...

Limerick, Pa.-based Teleflex, a global provider of medical devices for critical care and surgery, announced it will showcase its regional anesthesia and pain management products during the ESRA ...

And, in addition, Teleflex’s products are not as complex as medical devices in other areas of healthcare (with complexity a decent barometer for intangible assets), nor does the firm’s products ...

Teleflex plans to spin off its Urology, Acute Care, and OEM businesses into a new public company by mid-2026. Teleflex Incorporated announced its plan to separate its Urology, Acute Care, and OEM ...

Earnings call Teleflex reported Q1 2025 revenue of $700.7M, down 5% YoY (−3.8% adj. constant currency), and adjusted EPS of $2.91, down 9.3% YoY. Management reaffirmed full-year constant currency ...

Teleflex Incorporated has successfully completed its acquisition of the Vascular Intervention business from BIOTRONIK SE & Co. KG for €760 million. This acquisition enhances Teleflex’s portfolio in ...